Savara Inc.

Status: Publicly traded

Direct answer

Savara Inc. is publicly traded on NASDAQ under the ticker SVRA.

Savara Inc. is a biopharmaceutical firm in the clinical development phase, specializing in therapies for uncommon respiratory conditions. Their primary investigational drug, molgramostim, is an inhaled form of granulocyte-macrophage colony-stimulating factor (GM-CSF). This compound is currently undergoing Phase III trials to address autoimmune pulmonary alveolar proteinosis. The company's main operations are...

Can you invest in Savara Inc.?

Yes. Savara Inc. trades publicly on NASDAQ as SVRA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Savara Inc.

Detailed equity research is provided by MarketSnap.